NCT00091585View on ClinicalTrials.gov

Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors.

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2004

Study Completion Date

November 30, 2006

Conditions
Neoplasms
Interventions
DRUG

SNS-595

Trial Locations (4)

Unknown

Arizona Cancer Center, Scottsdale

Arizona Cancer Center, Tucson

Stanford University Medical Center, Stanford

Duke University Medical Center, Durham

Sponsors
All Listed Sponsors
lead

Sunesis Pharmaceuticals

INDUSTRY